Litcius/Paper detail

Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis

Mengya Shan, Ying Dai, Xiaodan Ren, Jing Zheng, Ke-bin Zhang, Bin Chen, Jun Yan, Zihui Xu

2021Journal of Integrative Medicine42 citationsDOI

Topics & Concepts

SteatosisBerberineFOXO1CholesterolMedicineInternal medicineSirtuin 1Nonalcoholic steatohepatitisLiver X receptorNonalcoholic fatty liver diseaseEndocrinologyPharmacologyChemistryDownregulation and upregulationBiochemistryFatty liverGeneTranscription factorDiseaseNuclear receptorBerberine and alkaloids researchLiver physiology and pathologyDrug-Induced Hepatotoxicity and Protection